Holy Hemp: New Jersey Court Partially Invalidates Hemp Law

On Oct. 10, 2024, a New Jersey Federal District Court made a big decision on hemp. The Court largely invalidated New Jersey’s recent attempt to tighten controls on “intoxicating hemp products” like Delta-8 and Delta-10, which were previously sold in gas stations, smoke shops, and convenience stores without much oversight. The state had put forward amendments aimed at restricting these products to those over 21 and regulating them like cannabis. New Jersey argued that it was time to clamp down on these sales, citing public health concerns and the rising number of minors getting their hands on these potent, unregulated products.

NJ Gov. Phil Murphy had signed off on these amendments despite admitting the law wasn’t perfect. For him, protecting minors was the priority. And today, the Court shared that sentiment—partially. It kept in place only the part that prevents the sale of these products to minors.

As for the rest of the amendment? The Court struck it down. The reason? It found that New Jersey’s approach violated federal law, essentially treating hemp products from out-of-state differently from those produced locally under the New Jersey Cannabis Regulatory Commission’s new process. This selective control crossed the line, according to the Dormant Commerce Clause of the Constitution and provisions in the Federal Farm Act, which stops states from blocking the transport of hemp products.

The Court’s decision made it clear that New Jersey does have the power to regulate these sales, but the amendments need legislative fine-tuning to meet federal standards. So, while New Jersey’s push to regulate intoxicating hemp is on pause, this is far from over.

Here’s where the decision makes things complicated for sellers: By Oct. 12, shops were supposed to pull these hemp products from the shelves, including Delta-8 drinks and THC-A gummies. That means, until New Jersey’s Cannabis Regulatory Commission issues new rules, those products are off-limits.

For anyone in the hemp or cannabis business in New Jersey, it’s a loud reminder—stay compliant, stay updated, and be ready to adapt quickly to changes.

by: Benjamin Sheppard of Norris McLaughlin P.A.
©2024 Norris McLaughlin P.A., All Rights Reserved

  • Related Posts

    How to Prepare for the Upcoming Filing Deadline Under the Corporate Transparency Act (CTA)

    The January 1, 2025 filing deadline under the CTA for filing beneficial ownership information reports (BOI reports) for reporting companies formed prior to January 1, 2024 is rapidly approaching. January…

    AI Transcripts and Investment Advisers: Embracing Technology While Meeting SEC Requirements

    AI Transcripts in Investment Advisory There has been a boom recently regarding investment advisers’ use of artificial intelligence (“AI”) to transcribe client and internal meetings. Among other applications, AI features…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    E. Coli Outbreak Linked to Carrots: Symptoms, Risks, and Recalled Brands

    • By admin
    • November 21, 2024
    • 6 views

    How to Prepare for the Upcoming Filing Deadline Under the Corporate Transparency Act (CTA)

    • By admin
    • November 20, 2024
    • 5 views
    How to Prepare for the Upcoming Filing Deadline Under the Corporate Transparency Act (CTA)

    Dow Jones Today: Stocks Little Changed as Investors Await Nvidia Earnings Report; Bitcoin Hits Another Record High

    • By admin
    • November 20, 2024
    • 5 views

    AI Transcripts and Investment Advisers: Embracing Technology While Meeting SEC Requirements

    • By admin
    • November 20, 2024
    • 6 views
    AI Transcripts and Investment Advisers: Embracing Technology While Meeting SEC Requirements

    Daily Walks Could Help You Live Over a Decade Longer

    • By admin
    • November 20, 2024
    • 7 views

    Trump Administration Tariffs: Considerations for U.S. and Global Companies

    • By admin
    • November 20, 2024
    • 7 views
    Trump Administration Tariffs: Considerations for U.S. and Global Companies